Kairos Pharma, Ltd. ( KAPA) - Stock Earnings
KAPA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -1.4 million USD | — USD |
| 2025Q4 | -1.4 million USD | — USD |
| 2026Q1 | -1.7 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
KAPA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -1.8 million USD | — USD |
| 2024 | -2.6 million USD | — USD |
| 2025 | -5.4 million USD | — USD |
| 2026 Est. | — | — |
KAPA
Price: $0.47
52 week price:
Earnings Per Share: -0.30 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 10.2 million